Omnicell, Inc. (OMCL) saw a big move last session, as the company’s shares fell by over 6% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This reverses the recent trend for OMCL as the stock is now up around 2% in the past one-month time frame.
This slump shouldn’t be too much of a surprise to investors, as the medication and supply management automation solutions provider has seen its current year earnings consensus move lower over the last 30 days. This suggests there may be more trouble down the road. So make sure to keep an eye on this stock going forward to see if this recent slump will continue, as the earnings picture definitely suggests that this might be the case.
OMCL currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
A better-ranked stock in the same sector is Cerner Corporation (CERN), holding a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
OMNICELL INC (OMCL): Free Stock Analysis Report
CERNER CORP (CERN): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research